1 recruiting, 1 terminated. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Recruiting 1, Terminated 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Respiratory Disease: new trials by email Literature Review of Respiratory Disease trials Research Report on Respiratory Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Caffeine as an Adjuvant Therapy for Late Preterm Infants With Respiratory Distress Caffeine citrate, Placebo - Prematurity, Respiratory Disease | Phase 2 / Phase 3 | Recruiting | Ministry of Health, Saudi Arabia | 134 | 2023-10-12 | 2025-06-27 |
| Efficacy of Fluticasone Propionate Associated With Salmeterol Using Inhalation Chamber Versus Placebo to Improve the Respiratory Function in Children Over Six Years of Age Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation With a Decline of FEV1 ≥10% From Pre Transplantation Seretide, Placebo - Stem Cell Transplant Complications, Respiratory Disease | Phase 3 | Terminated | Assistance Publique - Hôpitaux de Paris | 35 | 2021-05-21 | 2025-09-16 |
Respiration Disorders (2) · Bronchiolitis Obliterans (1) · Bronchopulmonary Dysplasia (1) · Premature Birth (1)
Lung Diseases (2) · Respiratory Tract Diseases (2) · Bronchial Diseases (1) · Bronchiolitis (1) · Bronchitis (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Infant, Newborn, Diseases (1) · Infant, Premature, Diseases (1) · Lung Diseases, Obstructive (1) · Lung Injury (1) · Obstetric Labor Complications (1) · Obstetric Labor, Premature (1) · Pregnancy Complications (1) · Urogenital Diseases (1)
Fluticasone-Salmeterol Drug Combination (1) · Sodium Chloride (1) · caffeine citrate (1)
Assistance Publique - Hôpitaux de Paris (1) · Ministry of Health, Saudi Arabia (1)
France (1) · Saudi Arabia (1)
Nehad Nasef (1)